Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Business Overview of Pipeline Products
Business Overview of Pipeline Products
Consolidated Financial Results for the Nine Months Ended September 30, 2025 (Under IFRS)
Business Overview of Pipeline Products (Second Quarter of the Fiscal Year Ending December 31, 2025)
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2025 (under IFRS)
Licensing Agreement for DARVIAS and episil in Southeast Asia, Oceania, Middle East, and Africa Regions, Sales Approval for episil in Singapore
Consolidated Financial Results for the Three Months Ended March 31, 2025 (Under IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (Under IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (Under IFRS)
Business Overview of Pipeline Products(First Quarter of the Fiscal Year Ending December 31, 2025)
Business Overview of Pipeline Products(First Quarter of the Fiscal Year Ending December 31, 2025)
Business Overview of Pipeline Products(First Quarter of the Fiscal Year Ending December 31, 2025)
Business Overview of Pipeline Products(First Quarter of the Fiscal Year Ending December 31, 2025)
Business Overview of Pipeline Products(First Quarter of the Fiscal Year Ending December 31, 2025)
Business Overview of Pipeline Products(First Quarter of the Fiscal Year Ending December 31, 2025)
Business Overview of Pipeline Products(First Quarter of the Fiscal Year Ending December 31, 2025)
Business Overview of Pipeline Products(First Quarter of the Fiscal Year Ending December 31, 2025)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (Under IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (Under IFRS)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (Under IFRS)